Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review

BACKGROUND: Ketamine has emerged as a rapid-acting antidepressant in treatment-resistant depression (TRD) increasingly used in non-research, clinical settings. Few studies, however, have examined neurocognitive effects of repeated racemic ketamine infusion treatments in patients with TRD. In an effo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Danika, Miller, Courtney, Valdivia, Violeta, Boyle, Brian, Bolton, Paula, Li, Shuang, Seiner, Steve, Meisner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862573/
https://www.ncbi.nlm.nih.gov/pubmed/35193541
http://dx.doi.org/10.1186/s12888-022-03789-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862573/
https://www.ncbi.nlm.nih.gov/pubmed/35193541
http://dx.doi.org/10.1186/s12888-022-03789-3

Ejemplares similares